Search Results - "Jamieson, Amy"

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer by Jamieson, Amy, Bosse, Tjalling, McAlpine, Jessica N.

“…Following the discovery of the four molecular subtypes of endometrial cancer (EC) by The Cancer Genome Atlas (TCGA) in 2013, subsequent studies used surrogate…”
Get full text

AI-based histopathology image analysis reveals a distinct subset of endometrial cancers by Darbandsari, Amirali, Farahani, Hossein, Asadi, Maryam, Wiens, Matthew, Cochrane, Dawn, Khajegili Mirabadi, Ali, Jamieson, Amy, Farnell, David, Ahmadvand, Pouya, Douglas, Maxwell, Leung, Samuel, Abolmaesumi, Purang, Jones, Steven J. M., Talhouk, Aline, Kommoss, Stefan, Gilks, C. Blake, Huntsman, David G., Singh, Naveena, McAlpine, Jessica N., Bashashati, Ali

“…Endometrial cancer (EC) has four molecular subtypes with strong prognostic value and therapeutic implications. The most common subtype (NSMP; No Specific…”
Get full text

Pseudomyxoma peritonei arising from mature ovarian teratoma, a rare entity: Report of six cases and review of current literature by Ha, Minah, Jamieson, Amy, Pickett, Justine, McGinnis, Justin M., De Greve, Tom

“…•Pseudomyxoma peritonei (PMP) arising from a mature ovarian teratoma is a rare entity with limited case reports in the literature.•Immunohistochemistry profile…”
Get full text

Surgical management of intravenous leiomyomatosis with intracardiac extension by Cohen, Danielle, Mordhorst, Alexa, Misskey, Jonathan, Jamieson, Amy, Faulds, Jason

“…Intravenous leiomyomatosis is a rare smooth muscle tumor that is associated with uterine leiomyomas. Intravenous leiomyomatosis often presents with nonspecific…”
Get full text

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice by Jamieson, Amy, McAlpine, Jessica N

“…Molecular classification provides an objective, reproducible framework for categorization of endometrial cancers (ECs), informing prognosis and selection of…”
Get more information

To the editor by Gilks, C. Blake, Jamieson, Amy, McAlpine, Jessica N., Singh, Naveena

Get full text

Response to: Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology? by Jamieson, Amy, Brand, Alison

Get full text

Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape by Jamieson, Amy, Barroilhet, Lisa M., McAlpine, Jessica N.

“…Lay summary Endometrial carcinoma (EC) classification and risk stratification have undergone a global transformation in the last decade, shifting from a…”
Get full text

Serum CA-125 levels in the context of ProMisE molecular classification provide preoperative prognostic information that can direct endometrial cancer management by Neilson, Andrea, Jamieson, Amy, Chiu, Derek, Leung, Samuel, Talhouk, Aline, McAlpine, Jessica

Get full text

Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence by Jamieson, Amy, Sykes, Peter, Eva, Lois, Bergzoll, Cecile, Simcock, Bryony

“…To compare three different patterns of stage IV epithelial ovarian cancer; pleural effusion, parenchymal metastases and extra-abdominal lymph node metastases…”
Get full text

The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype by Jamieson, Amy, Singh, Naveena, Huvila, Jutta, Gilks, C. Blake, McAlpine, Jessica N.

“…•NSMP molecular subtype includes ECs with diverse pathomolecular features and strikingly different clinical outcomes.•Two key features; ER status and grade…”
Get full text

p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification by Jamieson, Amy, Thompson, Emily F, Huvila, Jutta, Gilks, C Blake, McAlpine, Jessica N

“…Over the past decade, our understanding of endometrial cancer has changed dramatically from the two-tiered clinicopathologic classification system of type I…”
Get more information

A Scoping Review of Treatment Outcome Measures for Vulvar Intraepithelial Neoplasia by Jamieson, Amy, Tse, Samantha S., Proctor, Lily, Sadownik, Leslie A.

Get full text

p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis? by Kommoss, Felix K F, Jamieson, Amy, McAlpine, Jessica N, Gilks, C Blake

Get full text

Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics by Huvila, Jutta, Jamieson, Amy, Pors, Jennifer, Hoang, Lynn, Mirkovic, Jelena, Cochrane, Dawn, McAlpine, Jessica N, Gilks, C Blake

“…Our aim was to assess the molecular subtype(s) and perform a detailed morphologic review of tumors diagnosed as carcinosarcoma in a population-based cohort…”
Get full text

Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases by Jamieson, Amy, Thompson, Emily F., Huvila, Jutta, Leung, Samuel, Lum, Amy, Morin, Chantale, Ennour-Idrissi, Kaoutar, Sebastianelli, Alexandra, Renaud, Marie-Claude, Gregoire, Jean, Huntsman, David G., Gilks, C. Blake, Plante, Marie, Grondin, Katherine, McAlpine, Jessica N.

“…The role of lymph node assessment/dissection (LND) in endometrial cancer (EC) has been debated for decades, with significant practice variation between…”
Get full text

Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death by Jamieson, Amy, Huvila, Jutta, Chiu, Derek, Thompson, Emily F., Scott, Stephanie, Salvador, Shannon, Vicus, Danielle, Helpman, Limor, Gotlieb, Walter, Kean, Sarah, Samouelian, Vanessa, Köbel, Martin, Kinloch, Mary, Parra-Harran, Carlos, Offman, Saul, Grondin, Katherine, Irving, Julie, Lum, Amy, Senz, Janine, Leung, Samuel, McConechy, Melissa K., Plante, Marie, Kommoss, Stefan, Huntsman, David G., Talhouk, Aline, Gilks, C. Blake, McAlpine, Jessica N.

“…Endometrial carcinoma (EC) can be divided into 4 prognostic molecular subtypes, and no specific molecular profile (NSMP) type is the most commonly occurring…”
Get full text

To the editor by Gilks, C Blake, Jamieson, Amy, McAlpine, Jessica N, Singh, Naveena

Get full text

To the editor by Gilks, C Blake, Jamieson, Amy, McAlpine, Jessica N, Singh, Naveena

Get full text

Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype by Huvila, Jutta, Thompson, Emily F, Vanden Broek, Jamie, Lum, Amy, Senz, Janine, Leung, Samuel, Gilks, C Blake, Köbel, Martin, McAlpine, Jessica N, Jamieson, Amy

“…The significance of subclonal expression of p53 (abrupt transition from wild-type to mutant-pattern staining) is not well understood, and the arbitrary…”
Get full text